Advertisement

Related Videos

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Amit Sanyal, MD: A Clinician’s Perspective

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Advertisement

Advertisement




Aug
05
Today In Oncology
When Diagnosis Waits: Lung Cancer, PET Access, and Global Oncology
Phase I Trial Evaluates Allogeneic CD70-Targeted CAR T-Cell Therapy in Advanced Renal Cell Carcinoma
Combination Regimen Prolongs PFS in dMMR-MSI-H Metastatic Colorectal Cancer
CKM Syndrome Associated With Increased, Stage-Specific Cancer Risk, Study Finds
Population-Based MGUS Screening Enables Earlier Detection of Multiple Myeloma Without Increasing Psychological Distress
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo